Basic information
- CAS
39552-01-7- Standard SMILES
CC(=O)c1cc2cccc(OCC(O)CNC(C)C)c2o1- InChIKey
ZPQPDBIHYCBNIG-UHFFFAOYSA-N- Molecular formula
- C16H21NO4
- Average molar mass
- 291.34 g/mol
- Monoisotopic mass
- 291.14705815
Names & identifiers
- Preferred name
- Befunolol
- IUPAC
- 1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-1-benzofuran-2-yl]ethanone
- English name
- Befunolol
- Molecular formula
- C16H21NO4
- Molecular weight
- 291.34
Names & synonyms
Show more names
Database identifiers
- CAS
39552-01-7- PubChem CID
- 2309
- DTXSID
DTXSID80865957- ChEMBL
CHEMBL153984- ChEBI
CHEBI:135212- UNII
- 418546MT3A
- Nikkaji
- J16.631F
Properties
Computed structural properties
- XLogP
- 2
- Topological polar surface area
- 71.7 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 5
- Rotatable bonds
- 7
- Heavy atoms
- 21
- Formal charge
- 0
- Complexity
- 347
Experimental & physicochemical properties
Physicochemical properties
- Melting point
- 115 ° · 115°
- Boiling point
- 433.35 °C · 433.35°C (rough estimate)
- Density
- 1.1049 · 1.1049 (rough estimate)
- refractive index
- 1.55 · 1.5500 (estimate)
- storage temp.
- -20 °C · Hygroscopic, -20°C Freezer, Under inert atmosphere
- solubility
- Chloroform (Slightly), DMSO (Slightly, Heated)
- form
- Solid
- color
- White to Off-White
- CAS DataBase Reference
- 39552 · 39552-01-7
- EWG's Food Scores
- 1 · 1
- FDA UNII
- 418546 MT3A · 418546MT3A
- ATC code
- 1 ED06 · S01ED06
- Toxicity
- 50 in · LD50 in mice: 100-105 mg/kg i.v. (Ito)
Safety & regulation
Safety data
- Toxicity
- LD50 in mice: 100-105 mg/kg i.v. (Ito)
Chemistry & industry
Pharmacology
ATC Code
S - Sensory organs;S01 - Ophthalmologicals;S01E - Antiglaucoma preparations and miotics;S01ED - Beta blocking agents;S01ED06 - Befunolol
QS - Sensory organs;QS01 - Ophthalmologicals;QS01E - Antiglaucoma preparations and miotics;QS01ED - Beta blocking agents;QS01ED06 - Befunolol
MeSH Pharmacological Classification
Drugs that selectively bind to and activate beta-adrenergic receptors.
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
Applications
UsesBefunolol is a β-adrenergic blocker with an intrinsic sympathomimetic action. But it can work as a β-adrenergic partial agonist in isolated organs.
Usesβ-Adrenergic blocker used as antiglaucoma agent in ophthalmie solutions
Upstream & downstream products
Upstream raw materials
Suppliers13 total
Additional notes
DefinitionChEBI: Befunolol is a member of benzofurans.
Related reactions
Compound notes
Loading…